US medical devices industry saw a rise of 4.60% in overall deal activity during April 2021, when compared with the last 12-month average, led by $5bn merger of CA Healthcare Acquisition and LumiraDx, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 91 deals worth $9.6bn were announced in April 2021, compared with the 12-month average of 87 deals.

venture financing was the leading category in the month in terms of volume with 56 deals, which accounted for 61.5% of all deals.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In second place was M&A with 23 deals, followed by private equity with 12 transactions, respectively accounting for 25.3% and 13.2% of overall deal activity in the US technology industry during the month.

In terms of value of deals, M&A was the leading deal category in the US medical devices industry with total deals worth $7.41bn, while venture financing and private equity deals totalled $1.42bn and $727.8m respectively.

US medical devices industry deals in April 2021: Top deals

The top five medical devices industry deals accounted for 79.8% of the overall value during April 2021.

The combined value of the top five medical devices deals stood at $7.62bn, against the overall value of $9.6bn recorded for the month.

The top five medical devices industry deals of April 2021 tracked by GlobalData were:

1) The $5bn merger of CA Healthcare Acquisition and LumiraDx

2) The $1.8bn acquisition of Luminex by DiaSorin

3) The Carlyle Group’s $435m private equity deal with Unchained Labs

4) The $200m acquisition deal with Genosity by InVitae

5) Mountain Crest AcquisitionII’s acquisition of Better Therapeutics for $187m.